KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Non-Current Deffered Revenue (2016 - 2026)

Idexx Laboratories has reported Non-Current Deffered Revenue over the past 17 years, most recently at $32.2 million for Q4 2025.

  • For Q4 2025, Non-Current Deffered Revenue rose 19.44% year-over-year to $32.2 million; the TTM value through Dec 2025 reached $32.2 million, up 19.44%, while the annual FY2025 figure was $32.2 million, 19.44% up from the prior year.
  • Non-Current Deffered Revenue for Q4 2025 was $32.2 million at Idexx Laboratories, up from $31.1 million in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $44.2 million in Q1 2021 and troughed at $26.8 million in Q3 2024.
  • A 5-year average of $32.8 million and a median of $31.0 million in 2022 define the central range for Non-Current Deffered Revenue.
  • Biggest five-year swings in Non-Current Deffered Revenue: fell 25.22% in 2021 and later grew 19.44% in 2025.
  • Year by year, Non-Current Deffered Revenue stood at $41.2 million in 2021, then decreased by 25.04% to $30.9 million in 2022, then dropped by 7.55% to $28.5 million in 2023, then decreased by 5.59% to $26.9 million in 2024, then rose by 19.44% to $32.2 million in 2025.
  • Business Quant data shows Non-Current Deffered Revenue for IDXX at $32.2 million in Q4 2025, $31.1 million in Q3 2025, and $31.8 million in Q2 2025.